Investor Advisory

Message to Our Investors

Burcon NutraScience Corporation has taken reasonable care in preparing and publishing information on this web site on a regular basis. The information is not a substitute for detailed investigation or analysis on any particular issue and may not always be current. The contents of this web site are not and should not be used as a substitute for independent professional advice in making an investment decision, and Burcon NutraScience Corporation will not be responsible for any loss or damage arising from the use of this information.

The principal business objective of Burcon NutraScience Corporation is to commercialize its patented and patent-pending technologies for protein from soybean meal and canola meal. The technologies are at an early stage of development and the company’s future financial performance largely depends on the successful development of commercial products. Technological development has very high risks and there is no assurance that Burcon NutraScience Corporation’s extraction technology will ever be commercialized, or that Burcon NutraScience Corporation will be able to develop markets for its products. Burcon NutraScience Corporation has not generated revenues from its operations since inception in 1998. Although its technology is protected by patents and pending patents, Burcon NutraScience Corporation is subject to competition from other corporations which have greater financial and technical resources.

To the extent that any statements in this web site deal with information that is not historical, these statements are necessarily forward looking. As such, they are subject to the occurrence of many events outside of Burcon NutraScience Corporation’s control and are subject to various risk factors that could cause Burcon NutraScience Corporation’s results to differ materially from those expressed in any forward looking statement. The risk factors include, without limitation, the inherent risk of competition in the marketplace, outcomes in product trial studies, regulatory risks and risks related to proprietary rights and market acceptance. Differences may result from: a loss of key personnel; from an inability to raise sufficient capital to pay for technology development; from technological failure; from an inability to complete or maintain alliances with other companies; from an inability to effectively demonstrate or market the technology; from an inability to manufacture products with an acceptable cost and quality; from developments in world markets for protein, food ingredients or nutraceuticals; from local, regional or national political developments in Canada; or from the timing of regulatory approvals and other factors.